Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

被引：1
|
作者：
Alvarez, Ricardo H. [1 ]
Hortobagyi, Gabriel N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 124卷 / 03期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; INDUCTION CHEMOTHERAPY; PREDICTIVE MARKERS; DOXORUBICIN; SURVIVAL; WOMEN; CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10549-010-1212-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：701 / 705
页数：5
相关论文
共 50 条
  • [1] Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design
    Ricardo H. Alvarez
    Gabriel N. Hortobagyi
    Breast Cancer Research and Treatment, 2010, 124 : 701 - 705
  • [2] Primary systemic therapy in operable breast cancer
    Wolff, AC
    Davidson, NE
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1558 - 1569
  • [3] PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST-CANCER
    ANDERSON, EDC
    FORREST, APM
    HAWKINS, RA
    ANDERSON, TJ
    LEONARD, RCF
    CHETTY, U
    BRITISH JOURNAL OF CANCER, 1991, 63 (04) : 561 - 566
  • [4] Primary and adjuvant systemic therapy for operable breast cancer
    Thomssen, C.
    Huober, J.
    ONKOLOGE, 2008, 14 (05): : 504 - 513
  • [5] Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer
    Antonio Llombart-Cussac
    Ángel Guerrero
    Antonio Galán
    Vicente Carañana
    Elvira Buch
    Álvaro Rodríguez-Lescure
    Amparo Ruiz
    Carlos Fuster Diana
    Vicente Guillem Porta
    Clinical and Translational Oncology, 2012, 14 : 125 - 131
  • [6] Oestrogen receptor directed primary systemic therapy: a randomised trial compared with conventional therapy in operable breast cancer.
    Cameron, DA
    Jack, W
    Forouhi, P
    Keen, J
    Dixon, JM
    Leonard, RCF
    Chetty, U
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S52 - S52
  • [7] Adjuvant systemic therapy for operable breast cancer
    Narayanan, S.
    Taylor, I.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2007, 5 (02): : 101 - 106
  • [8] Proliferation and apoptosis before and after primary systemic therapy for operable breast cancer
    Guarneri, V.
    Piacentini, F.
    Frassoldati, A.
    Ficarra, G.
    Jovic, G.
    Puglisi, F.
    Michelotti, A.
    Bisagni, G.
    Berardi, R.
    Conte, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Primary systemic therapy for operable breast cancer: A review of clinical trials and perspectives
    Guarneri, Valentina
    Frassoldati, Antonio
    Giovannelli, Simona
    Borghi, Francesca
    Conte, PierFranco
    CANCER LETTERS, 2007, 248 (02) : 175 - 185
  • [10] Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[ plus ] operable breast cancer
    Llombart-Cussac, Antonio
    Guerrero, Angel
    Galan, Antonio
    Caranana, Vicente
    Buch, Elvira
    Rodriguez-Lescure, Alvaro
    Ruiz, Amparo
    Fuster Diana, Carlos
    Guillem Porta, Vicente
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (02): : 125 - 131
12345